| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP Research | Officer Level 14 | EVP, Research +1 more
1 company
Swayze Eric is an EVP Research at IONIS PHARMACEUTICALS INC. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $3.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sell | 6,179 | $82.93 | $512,446.10 | -11.5% | -9.6% | - | |
| Jan 2, 2026 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sale+OE | 23,463 | $79.12 | $1,856,324.51 | -27.8% | -6.1% | - | |
| Oct 16, 2025 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sale+OE | 53 | $73.62 | $3,901.93 | -17.2% | +7.9% | - | |
| Oct 6, 2025 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sell | 6,849 | $69.02 | $472,717.98 | -18.4% | +13.8% | - | |
| Oct 2, 2025 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sale+OE | 27,114 | $66.16 | $1,793,744.13 | -26.7% | +15.7% | - | |
| Sep 2, 2025 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sell | 11,130 | $49.67 | $552,861.68 | -12.8% | +42.6% | - | |
| Jan 31, 2025 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sell | 1,367 | $32.31 | $44,162.03 | -2.8% | -0.6% | +159.2% | |
| Jan 16, 2025 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sale+OE | 7,176 | $32.84 | $235,678.22 | -13.5% | -12.2% | +136.5% | |
| Nov 12, 2024 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sell | 1,194 | $37.92 | $45,277.67 | -3.4% | -16.7% | +92.4% | |
| Oct 16, 2024 | IONS Ionis Pharmaceuticals Inc | EVP Research | Sale+OE | 53 | $38.31 | $2,030.59 | -25.2% | -16.5% | +86.6% |